Transplant diagnostics Market to Witness a Pronounce Growth During 2016 – 2027

Global Transplant diagnostics Information, by technology (molecular assays, non-molecular assays and others), by application (Diagnosis, Research and others), by products (Reagents, instruments, services and others), by end users (Hospitals, clinics, diagnostic centers and others) – Forecast to 2027

Market Highlights:

Constant efforts taken by healthcare research and development resulting into the development of technically advanced treatment for the patients suffering from organ failure. As the result, the adoption of these highly advanced organ transplantation techniques is creating upsurge demand for transplant diagnostics as these techniques will reduce the risk of infections through pre-operative assessments which will determine the tissue compatibility prior to organ transplants.

Market for Transplant diagnostics is booming due to an increasing number of patients suffering from chronic diseases leading to organ failure which is creating the demand for transplant procedures.

Key Players for Transplant diagnostics Market:

  • Thermo Fisher Scientific Inc. (U.S)
  • Bio-Rad Laboratories, Inc. (U.S)
  • Biogenuix (India)
  • Abbott Laboratories (U.S)
  • Transplant Biomedicals (Barcelona)
  • bioMérieux SA (France)

Request a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/1324

Intended Audience:

  • Transplant diagnostics manufacturers
  • Transplant diagnostics suppliers
  • Government research laboratories
  • Research and Development (R&D) Companies
  • Independent Research Laboratories
  • Market Research and Consulting Service Providers
  • Medical Research Laboratories

Segments:

Global Transplant diagnostics market has been segmented on the basis of technology which comprise of molecular assays, non-molecular assays and others. On the basis of product which comprise of reagents, instruments, software and others. On the basis of application which comprise of research, diagnosis and others On the basis of end users; market is segmented into Hospitals, clinics, diagnostic centers and others.

Taste the market data and market information presented through more than 50 market data tables and figures spread in 115 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Transplant diagnostics Market Research Report- Forecast To 2027

Access Report Details @ https://www.marketresearchfuture.com/reports/transplant-diagnostics-market

Study Objectives of Transplant diagnostics Market:

  • To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the Transplant diagnostics market  
  • To provide insights about factors affecting the market growth
  • To analyze the Transplant diagnostics market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
  • To provide country level analysis of the market with respect to the current market size and future prospective
  • To provide country level analysis of the market for segments by technology, by product, by application, by end users and its sub-segments.
  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Transplant diagnostics market.

Make an Enquiry @ https://www.marketresearchfuture.com/enquiry/1324

The report for Global Transplant diagnostics Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance.

The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market.

Browse Related Reports:-

Spinal implants market information, by type (fusion implants, non-fusion implants), by procedure (open surgery, minimally invasive surgery) by material (titanium, titanium-alloy, stainless steel, and plastic) – Forecast till 2022

https://www.marketresearchfuture.com/reports/spinal-implants-market-2050

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/transplant-diagnostics-market

Pharmacogenomics Market 2017 Size, Development Status, Type And Application, Segmentation, Forecast By 2027

Global Pharmacogenomics Market Information by Application (drug safety, Tailor treatments, drug discovery), By Therapeutic application (cancer, oncology, cardiovascular) By Methods (haplotype analysis, multivariate techniques) – Forecast to 2027

Market Highlights:

Pharmacogenomics are popularly known as personalized medicines and are defined as Customized/ personalized medicines or customized medical treatment to the specific characteristics of each patient. This notion basically, comprises the ability to classify individuals into the groups or categories that are uniquely or excessively prone to a particular disease or responsive to a specific treatment.

Emergence of new healthcare technologies and rapid advancement such as GenX sequencing, Digital Polymerase Chain Reaction (PCR) and High Throughput Screening (HTS), are the key driving factors for the global market of Pharmacogenomics.

With the increasing demand for diagnostic tests leaded by the growing emphasize of patients on pre-diagnosis treatments, increasing genetic disorders & mutational diseases, and government initiatives and investment in research and development programs, the Diagnostic Test segment has out grown the other segments holding the largest market share.

Key Players

  • Myriad Genetics, Inc (U.S)
  • Transgenomic, Inc(U.S)
  • 23andMe (U.S)
  • Pathway Genomics (CA)
  • Genetech (CA)
  • GeneDX (U.S)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Illumina, Inc.(U.s)
  • Assurex Health, Inc.(U.s)

Request a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/1177

Global Pharmacogenomics Market’s Current trends are prompting the service provider segments to collaborate and entering into partnerships with healthcare providers, academic institutions, pharmaceuticals and biotechnology companies to support the growth of the Pharmacogenomics market and thus, service segment is anticipated to grow at a high CAGR from 2016 to 2027

Furthermore, the Pharmaceutical segment will also gain from traction of the patients due to increasing awareness about the benefits of Pharmacogenomics solutions and adoption of these solutions in developing regions.

The report for Pharmacogenomics of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance.

Segments

The market for pharmacogenomics is segmented into mainly three; by application, by therapeutic application, by end user and its various sub-segments. By application include drug safety, Tailor treatments, drug discovery and others. Whereas by therapeutic application include cancer, oncology, cardiovascular and others. Furthermore by methods include haplotype analysis, multivariate techniques, quantitative trait analysis and others.

Taste the market data and market information presented through more than 50 market data tables and figures spread in 120 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Pharmacogenomics Market Research Report – Forecast to 2027

Access Report Details @ https://www.marketresearchfuture.com/reports/pharmacogenomics-market

Study Objectives of Pharmacogenomics

  • To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the global pharmacogenomics market
  • To provide insights about factors affecting the market growth
  • To Analyze the Pharmacogenomics Market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia, and Middle East & Africa.
  • To provide country level analysis of the market with respect to the current market size and future prospective
  • To provide country level analysis of the market for segment by application, by therapeutic application, by methods and its sub-segments.
  • To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global pharmacogenomics market.

Make an Enquiry @ https://www.marketresearchfuture.com/enquiry/1177

Americas

  • North America
  • US
  • Canada
  • Latin America

Europe

  • Western Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Rest of Western Europe
  • Eastern Europe

Asia– Pacific

Asia

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia

Pacific

The Middle East& Africa

The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.

Browse Related Reports:-    

Global Infusion Systems market, by Product Type (Ambulatory Pumps, I.V. Disposables, Syringe Pump Systems, Volumetric Pump Sets and others), by applications (chemotherapy, cardiovascular diseases, Diabetes, Pediatrics and others) by end users (Hospitals, Clinics, Research Laboratories and others) – Forecast to 2027

https://www.marketresearchfuture.com/reports/infusion-systems-market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/pharmacogenomics-market

Nanobots Market to Witness a Pronounce Growth During 2016 – 2027

Global Nanobots Information, by Types (Microbivore nanorobots, Respirocyte nanorobots, Clottocyte nanorobots, Cellular repair nanorobots and others ), by Applications (Nano medicine, mechanical, healthcare, biomedical and others) – Forecast to 2027

Market Highlights:

Nanobots will be the next generation of Nano machines. Nanobot are an extremely small machine designed to perform a specific task on a microscopic scale. They have potential applications in the assembly and maintenance of sophisticated systems.

Nanobots will help bridge the technological gaps between physics, chemistry and biology on the Nano-scale. Nanobots might produce copies of themselves to replace worn-out units.

Major Key Players

  • Xidex Corp.
  • Zymergen Inc.
  • Synthace Limited
  • GINKGO BIOWORKS

Request a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/1301

The report for Global Nanobots Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance.

Market Segments:

Segmentation by types

  • Microbivore nanorobots
  • Respirocyte nanorobots
  • Clottocyte nanorobots
  • Cellular repair nanorobots

Segmentation by application market

  • Nano Medicine
  • Mechanical
  • Healthcare
  • Biomedical

Taste the market data and market information presented through more than 50 market data tables and figures spread in 130 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Nanobots Market Research Report- Forecast To 2027

Access Report Details @ https://www.marketresearchfuture.com/reports/nanobots-market

Study Objectives of Nanobots Market:

  • To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the Nanobots market  
  • To provide insights about factors affecting the market growth
  • To analyze the Nanobots market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
  • To provide country level analysis of the market with respect to the current market size and future prospective
  • To provide country level analysis of the market for segments by types, by applications and its sub-segments.
  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in theglobal Nanobots market.

Make an Enquiry @ https://www.marketresearchfuture.com/enquiry/1301

Americas

  • North America
  • US
  • Canada
  • Latin America

Europe

  • Western Europe
  • Germany
  • France
  • Italy
  • Spain
  • U.K
  • Rest of Western Europe
  • Eastern Europe

Asia– Pacific

  • Asia
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia
  • Pacific

The Middle East& Africa

The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/nanobots-market

Global Veterinary Imaging market is growing steadily at the CAGR of 4.7% by 2023

Veterinary Imaging Market information, by type (Radiology, Ultrasound, CT scan, Endoscopy, Magnetic Resonance Imaging (MRI), and Others), by application (Orthopedic, Dental, Oncology, Cardiology, and others); by type of animal (Canines, Felines), by End User (Veterinary Hospitals and clinics, Research centers, and others) – Forecast to 2023

Market Highlights

The global Veterinary Imaging market has been evaluated as steadily growing market and it is expected that the market will continue to grow similarly in the near future. Veterinary deals with diagnosis and treatment of diseases in animals. Veterinary imaging devices are useful in diagnosis and treatment of diseases in animals. These devices also give clear understanding of disease or injury that helps veterinarian for treatment of animal. Increasing awareness about animal healthcare and improvement of animal life are key factors for the growth of the market. Disease pattern in animals are continuously changing and becoming more challenging for veterinarians to diagnose these diseases.

Veterinary imaging devices give them in accurate diagnosis and further treatment. Increasing pet adoption is another major factor for the growth of the market. Increasing number of veterinarians, veterinary clinics and growing veterinary healthcare infrastructure are driving the growth for the market. Cattles are very important part of farming that have economic importance because they provide many products like milk, meat and leather. Farmers are becoming more aware about the health of their cattle which is good sign for the growth of the market.

Major Key Players:

  • Atlantis Worldwide (US),
  • Canon Inc. (Japan),
  • Diagnostic Imaging Systems, Inc. (US),
  • Fujifilm Holdings Corporation (Japan),
  • GE Healthcare (US),
  • Hitachi, Ltd (Japan),
  • Medical Imaging / IMCO, Inc. (US),
  • Sectra (Sweden),
  • Siemens AG (Germany),
  • Toshiba Medical Systems Corporation (Japan)

Request a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/2919

About 75% of veterinarians are working in private hospitals or pet clinics and these hospitals or clinics are spending money in advancement of technology to provide better facilities. Veterinary imaging devices manufacturers are spending money to develop innovative and usable product for the market. However there are some factors which are inhibiting the growth of the market such as high cost of devices that small clinics cannot afford, lack of knowledge about new technology or products, availability of products, access to veterinary healthcare facilities, lack of skilled veterinary professionals etc.

The global veterinary imaging market was around US$ 873.2 million in 2016 and is expected to reach US$ 1204.3 million by 2023 at the CAGR of 4.7% during the forecast period.

Test the market data and market information presented through more than 67 market data tables and figures spread over 84 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Veterinary Imaging Market Research Report – Global Forecast to 2023.”

Access Report Details @ https://www.marketresearchfuture.com/reports/veterinary-imaging-market-2919   

Segmentation:

Veterinary Imaging market has been segmented on the basis of type which comprises Radiology, Ultrasound, CT scan, Endoscopy, Magnetic Resonance Imaging (MRI), and Others. On the basis of application, the market is segmented into Orthopedic, Dental, Oncology, Cardiology, and others. On the basis of animal market segmented into Canines, Felines, and Large Animals. On the basis of end user, market is segmented into Veterinary Hospitals and clinics, Research centers, and others.

Regional Analysis:

Depending on geographic region, Veterinary Imaging market is segmented into four key regions: Americas, Europe, Asia-Pacific, and Middle East & Africa. Considering the global scenario of the market, North America is believed to be the largest market for Veterinary Imaging. Moreover the European market is also growing and second largest market for Veterinary Imaging. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the Veterinary Imaging during the forecasted period. Rest of the World is likely to have a limited but steady growth in the market.

Make an Enquiry @ https://www.marketresearchfuture.com/enquiry/2919

Brief TOC

1.     Report Prologue

2.     Introduction

2.1    Definition

2.2    Scope of the Study

2.2.1  Research Objective

2.2.2  Assumptions

2.2.3  Limitations

2.3    Market Structure

2.4.   Market Segmentation

3.      Research Methodology

3.1    Research Process

3.2    Primary Research

3.3    Secondary Research

3.4    Market Size Estimation

3.5    Forecast Model

4.     Market Dynamics

Continued….

Browse Related Report

Global Lancet Information, by Types (Personal, Safety); by End-users (Hospitals & Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics, Others) – Forecast to 2022

https://www.marketresearchfuture.com/reports/lancet-market-2078

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/data-analytics-market

Insomnia Therapeutics Pipeline Analysis, 2017 – Clinical Trials & Results, Patent and Other Developments

Insomnia therapeutic pipeline analysis is expected to experience vast growth in future, with the increasing level of stress being the major contributor for the rising prevalence of the disease. Some of the other major factors driving the pipeline for insomnia include lifestyle diseases, smoking, alcohol and tobacco consumption and increasing health awareness. According to the data by American Academy of Sleep Medicine, every year eight million people suffer from insomnia in the U.S. It is believed that the disease is more commonly found in females as compared to males.

Explore Report at: www.psmarketresearch.com/market-analysis/insomnia-therape…

Insomnia is an intricate condition which involves difficulty in sleeping. It is categorized into two types based on its duration, acute insomnia and chronic insomnia. Acute insomnia is short-termed and frequently happens because of the increasing stress in. This type of insomnia does not require treatment and resolves itself. Chronic insomnia is a severe problem when a person is unable to sleep for at least three nights per week and this lasts for more than three months. Chronic insomnia is caused by several factors including changes in environment, work stress, certain medications and other clinical diseases. Sometimes, chronic insomnia is also linked with other psychiatric problems, which makes it difficult to diagnose. Some of the other causes of insomnia include asthma, arthritis, hyperthyroidism, parkinson’s disease, lower back pain, chronic pain, gastrointestinal problems and nasal allergies. Some medications such as medicines prescribed for high blood pressure, asthma, birth control, heart disease and nasal allergies, can also cause insomnia. Common symptoms of insomnia include tiredness, mood swings, change in behaviour, problems in relationships and others. Insomnia is diagnosed by physical examination and analysing the symptoms in an individual. Insomnia is treated by using several approaches which includes cognitive behavioral therapy, relaxation training and medication treatment. Some marketed medicines for insomnia includes non-benzodiazepine hypnotics, melatonin receptor agonists and benzodiazepine hypnotics.

Request for Table of Content at: www.psmarketresearch.com/market-analysis/insomnia-therape…

Some of the companies having a pipeline of insomnia therapeutics include Eisai Co., Ltd., Actelion Pharmaceuticals Ltd., Ache Laboratorios Farmaceuticos S.A., Merck Sharp & Dohme Corp., Evotec AG, Bristol-Myers Squibb Company, Johnson & Johnson, Alexza Pharmaceuticals, Inc., Reviva Pharmaceuticals Inc., Shionogi & Co., Ltd., Novartis AG, Takeda Pharmaceutical Company Limited, Neurim Pharmaceuticals Ltd., Heptares Therapeutics Limited, Intra-Cellular Therapies, Inc.

Browse Other Related Report at: www.psmarketresearch.com/industry-report/pharmaceuticals

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
Kundan
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY – 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: www.psmarketresearch.com

This release was published on openPR.

HIV-1, Cancer and Splicing: The Triangle

Join the Boston Biotech Meetup for Advances in Gene Therapy, an evening of networking, presentations and discussion with local scientists.

BOSTON, MA – 22 May, 2017 – The Boston Biotech Meetup is featuring the work of Dr. Parmit Kumar Singh at Advances in Gene Therapy on June 6, 2017 in Boston.

RSVP for this free event at: http://meetup.com/bostonbiotech

Dr. Singh will be presenting HIV-1, cancer and splicing: the triangle.

HIV-1 based vectors are popular in gene therapy to avoid oncogene activation by gamma retrovirus based vectors in gene therapy recipients. However, there is not much information about whether HIV-1 shows preference for cancer genes. Therefore, to understand the mechanism of LEDGF/p75-dependent integration, Dr. Singh determined 1 million unique integration sites of HIV-1 in human cultured cells by pair-end Illumina sequencing.

Bioinformatic analysis of these integration sites showed that HIV-1 prefers integration into cancer genes were preferentially targeted. The result is significant as it stresses the need for further study to design a safe HIV-1 based vector for gene therapy by considering the associated risk.

Further, Dr. Singh developed new methods to do bioinformatics analysis of these one million integration sites. By this new method it was found that HIV-1 prefers integration into genes with more number of introns or highly spliced genes. Also, it showed that the preference for integration into highly spliced genes depends on LEDGF/p75.

This was a very significant result as it not only suggests the cellular role of LEDGF/p75 in splicing but also it suggests a link between the normal cellular process splicing, HIV-1 integration and cancer as it is known that misregulation of splicing causes many disease like cancer. Further studies to understand the mechanism of splicing and its role in HIV-1 integration are needed to develop a better picture.

Dr. Parmit Kumar Singh completed his PhD at Centre for Cellular and Molecular Biology (CCMB), Hyderabad, India. Dr. Singh determined the threshold size of duplicated DNA that titrates repeat induced point mutation (RIP) machinery. Moreover, He identified the first wild-isolate strain of Neurospora as a dominant suppressor of meiotic silencing. Both RIP and meiotic silencing are genome defense process in Neurospora.

During his postdoc at National Institutes of Health, he researched the integration preference of HIV-1 and his results, based on one million integration sites of HIV-1 in human cultured cells, showed that HIV-1 has preference for the highly spliced and cancer genes. The result was published in Genes and Development.

Dr. Singh has also taught at the Foundation for Advanced Education in the Science (FAES), and Uniformed Services University of the Health Sciences (USUHS), Bethesda, Maryland, USA.

Media Contact
Company Name: Boston Biotech Meetup
Contact Person: Maureen Gilreath
Email: bosbiotech@gmail.com
Phone: 6176520002
Country: United States
Website: http://meetup.com/bostonbiotech

NUTRIBAND INC ANOUNCES THE ACQUISITION OF ADVANCED HEALTH BRANDS INC. AND TD THERAPEUTICS INC.

OVIEDO, FL – 22 May, 2017 – Nutriband Inc., a Nevada Corporation, is pleased to announce the signing of the acquisition agreement with Advanced Health Brands Inc. on May 22, 2017. According to the agreement Nutriband Inc. will acquire 100% of Advanced Health Brands Inc. and TD Therapeutics in exchange for 5,000,000 common shares of Nutriband Inc.

TD Therapeutics will now become Nutriband Life Sciences, A Pharmaceutical division of Nutriband Inc. with a focus on cardiovascular disease, metabolic disorders, cancer therapies and diagnostics.

Advanced Health Brands, is a U.S. based nutritional supplement / OTC company. Along with its sister company TD Therapeutics, a U.S. based pharmaceutical company we are creating an impressive platform to develop supplements for wellness and balanced living as well as medicines to treat diseases in multiple areas of medicine. We are focused on enhancing lives through the development, research and marketing of innovative therapeutic solutions and drug delivery systems.  

Advanced Health Brands Inc. is also the holder of the following provisional patents.

  • – Transdermal drug delivery system to address lipid regulating conditions.  The primary cause of cardiovascular disease is atherosclerotic plaque formation due to abnormal lipid regulating conditions.  (APP Number:  62455473,  EFS ID 28280308).
  • – Transdermal drug delivery system to address infections caused by susceptible organisms. Most anti-infective agents require multiple doses in a 24 hour period and have extensive side effect profiles.  Transdermal drug delivery systems provide a more patient friendly, efficient, and cost effective alternative for patients.  (APP Number:  62455476,  EFS ID 28280338).
  • – Transdermal drug delivery system (TDDS) to address gastroesophageal reflux disease. Gastroesophageal reflux disease (GERD) is a condition in which the digestive acid in the stomach comes in contact with the esophagus. The irritation caused by this disorder is known as heartburn. Longterm contact between gastric acids and the esophagus can cause permanent damage to the esophagus. Esomeprazole reduces the production of digestive acids, thus minimizing their effect on the esophagus. TDDS can reduce drug to drug interactions and can reduce potential side effects for patients.  (APP Number:  62455487,  EFS ID 28280365).
  • – Transdermal drug delivery system to address glycemic control individuals with type 2 diabetes and the widespread lipid abnormalities in the course of diabetes triggered dyslipidemia as hypercholesterolemia, hypertriglyceridemia, elevated LDL and decreased HDL. TDDS will provide a steady state treatment in order to provide better patient outcomes and better patient compliance. (APP Number: 62455500,  EFS ID 28280411).
  • – Transdermal drug delivery system to address hypertension and widespread lipid abnormalities in the course of cardiovascular disease triggered by dyslipidemia as hypercholesterolemia, hypertriglyceridemia, elevated LDL and decreased HDL. Cardiovascular disease burden is increasing all over the world. Cardiovascular disease is the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030.  (APP Number:  62455507,  EFS ID 28280431).
  • – Transdermal drug delivery system to address the maintenance treatment of asthma and to relieve the symptoms of seasonal allergy.  Researchers think nasal allergies affect about 50 million people in the United States. Allergies are increasing. They affect as many as 30 percent of adults and 40 percent of children. Allergic disease, including asthma, is the fifth leading chronic disease in the U.S. in people of all ages. It is the third most common chronic disease in children under 18 years old. (APP Number: 62455509,  EFS ID 28280445).

Nutriband Inc. has appointed Ray Kalmar the President of Nutriband Inc. and to the Board of Directors. Mr Kalmar has over ten years experience in the pharmaceutical industry with a particular specialization in cardiovascular disease, infections disease and pulmonology.  Mr Kalmar has also had extensive experience in pharmaceutical IP, Bulk Chemical supply (5 years) and pharmacognostics.  He received a Bachelor of Science, University of Central Florida. Mr Kalmar served 12 years with the United States Air Force as a combat medic.

Nutriband Inc. has appointed Paul Murphy as the Chief Operations Officer of Nutriband Inc. and to the Board Of Directors. Mr Murphy has over ten years experience in the Bulk Chemical Compounding market.  He was the Regional Sales Manager within the territories of Michigan, Indiana, Ohio, Illinois, Wisconsin, Tennessee and Kentucky for over 5 years.  Mr Murphy has over ten years experience as a CAD cleanroom specialist with consulting knowledge in USP 795, USP 797 and USP 800 compounding regulation.  He also has 5 years experience within the Outsourcing Facility (503B) market and specializes in cGMP guidelines for manufacturing.  He has a further 4 years consulting experience within the compounding market and 4 years orthopedic surgery experience.  Mr. Murphy received Bachelor of Science, Marketing at Central Michigan University.

About Nutriband Inc.

Nutriband is a unique, result’s driven, health and pharmaceutical Company based in Orlando Florida.  Unlike traditional health product companies, Nutriband found its start by spotting and targeting a gross and virtually unexplored niche in the supplement market through its method of ingredient delivery. All Nutriband products are based around the science of transdermal / Topical technologies. From what started in only Supplements, Nutriband has now also developed an impressive platform to develop drugs and diagnostic systems that treat diseases in many areas of medicine and supplementation.

For more information, visit: www.nutriband.com

About Our Forward-Looking Statements

Certain statements contained in this press release, including, without limitation, statements containing the words “believes”, “anticipates”, “expects” and words of similar import, constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  Such forward-looking statements involve both known and unknown risks and uncertainties.  Our actual results may differ materially from those anticipated in our forward-looking statements as a result of a number of factors, including our ability to create, sustain, manage or forecast our growth; our ability to attract and retain key personnel; changes in our business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions.  Except as required by applicable law, we undertake no obligation to revise or update any of our forward-looking statements in order to reflect any event or circumstance that may arise after the date hereof.

Media Contact
Company Name: Nutriband Inc
Contact Person: Gareth Sheridan
Email: gareth@nutriband.com
Phone: 3858813385
Country: United States
Website: www.nutriband.com

Irradiation Apparatus Market Research Report: Technological breakthroughs, Value chain and stakeholder analysis by 2023

Global Irradiation Apparatus Market: Overview

Irradiation apparatus refer to devices capable of producing ionizing radiations such as x-rays, gamma rays, high speed neutron, alpha and beta particles, and electrons. A variety of instrument used across a number of applications and end-use sectors utilize irradiation features, with the fields of medicine and research being the primary takers. In the past few years, the market for irradiation apparatus has witnessed a significant rise in technological advancements and the entry of portable devices for use across veterinary, dental, and pediatric diagnosis. The market has witnessed growth at a healthy pace owing to the increased demand from key application sectors and the trend is expected to remain strong over the next few years as well.

This report on the global market for irradiation apparatus presents a complete study of notable trends in the market and factors such as growth drivers, restraints, regulations, and competition, which are expected to have a significant influence on the overall future development of the market. The report provides several forward-looking statements denoting the growth prospects of the market and its key segments over the period between 2016 and 2024. A detailed analysis of the recent technological developments to have hit the market, the competitive landscape of the global market, and the regulatory scenario across key regional markets is also included in the report.

Global Irradiation Apparatus Market: Trends and Opportunities

The key forces leading to the increased usage of irradiation apparatus include the advent of new and more convenient product varieties. The easy availability of portable irradiates apparatus has increased their uptake in hospitals and clinics for a variety of purposes including diagnosis, therapeutics, chiropractic diagnosis, and dental diagnosis.

Advent of new technologies has encouraged the pharmaceutical and medical industries to increase their usage of irradiation apparatus, driving the overall growth of the market. Introduction of products such as laser beam and rotary laser irradiation apparatus, used widely to undertake linear welding with a uniform width has increased the set of potential industrial applications of irradiation apparatus in the recent past.

However, the market faces growth restraints such as strict regulatory aspects involved in the usage, storage, sale, and disposal of irradiation apparatus. Moreover, the high costs of these devices is another key restraint challenging the overall growth prospects of the market for irradiation apparatus, especially across developing or less developed economies.

View Report-

www.transparencymarketresearch.com/irradiation-apparatus-…

Global Irradiation Apparatus Market: Geographical and Competitive Dynamics

From a geographical standpoint, the report examines the market for irradiation apparatus across regions such as Asia Pacific, North America, Europe, and Middle East and Africa. Of these, the market in North America is presently the dominant market owing to the presence of some of the world’s leading pharmaceutical companies and thus the vast scope of application of irradiation apparatus in the region. Europe, another leading region in the pharmaceutical sector, is also one of the leading contributors to the overall revenue of the global irradiation apparatus market.

The Asia Pacific market holds a significant future growth opportunity owing to a thriving pharmaceutical industry and rising government interventions aimed at the development of the sector. As a number of international pharma giants extend their roots in the region through high-end manufacturing facilities, the need for irradiation apparatus will be felt at an encouraging pace in the region over the next few years.

Some of the leading players operating in the global irradiation apparatus market are Philips Healthcare, Carestream Health Inc., Agfa Gevaert NV, Toshiba America Medical Systems Inc., Fujifilm Holdings Corporation, Varian Medical Systems Inc., Siemens Healthcare, Hitachi Ltd., and Ziehm Imaging, Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

Market segments and sub-segments

Market trends and dynamics

Supply and demand

Market size

Current trends/opportunities/challenges

Competitive landscape

Technological breakthroughs

Value chain and stakeholder analysis

The regional analysis covers:

North America (U.S. and Canada)

Latin America (Mexico, Brazil, Peru, Chile, and others)

Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)

Eastern Europe (Poland and Russia)

Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)

Middle East and Africa (GCC, Southern Africa, and North Africa)

Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Irradiation Apparatus Market during 2015- 2023

www.transparencymarketresearch.com/sample/sample.php?flag…

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: www.transparencymarketresearch.com

This release was published on openPR.

Lactose monohydrate Market Research Report: Technological breakthroughs, Value chain and stakeholder analysis by 2023

Lactose monohydrate is an organic compound with the chemical formula C12H22O11. It is crystalline form of milk powder. It is employed as an pharmaceutical filler for the production of capsules and tablets. Lactose monohydrate is also known as milk sugar in the industry as it is a disaccharide sugar obtained from galactose and glucose found in milk. Lactose monohydrate appears as a white solid powder or pale yellow crystalline solid with a specific odor identical to milk. Lactose monohydrate is soluble in water. It is synthesized industrially through a two step process. First step involves crystallization of lactose solution by cooling to form crystals. Second step involves segregation of lactose crystals by centrifugation followed by drying. Lactose monohydrate has been generally recognized as safe (GRAS) for use in controlled quantities as an additive in edible products.
Lactose monohydrate finds application in a wide array of foods, beverages, cosmetics, pharmaceuticals and animal feed. Lactose monohydrate has been found to have a bland flavor and is utilized as a stabilizer for formulations. It has a longer shelf-life and is cheaper than real milk. Lactose monohydrate is primarily used as an additive in the formulation of several pharmaceuticals, nutraceuticals, foods and beverages. It is often used in tablets capsules, ready-mix infant formulas, chocolates, biscuits, ready-to-make foods, candies, ice-cream and bread and bakery products to enhance aroma and flavor. Lactose monohydrate is used in pharmaceuticals and animal feed as a filler because of its physical and chemical stability. Additionally, Lactose monohydrate is easy to mix with other ingredients and does not absorb water. Cheaper prices and longer shelf-life are the key benefits of using Lactose monohydrate. It is the most commonly available and most widely utilized milk sugar because of its stabilizing effect and easy solubility with water.

View Report-

www.transparencymarketresearch.com/lactose-monohydrate-ma…

The lactose monohydrate market is mainly driven by its demand from the pharmaceuticals and food and beverages industry. Additionally, increasing adoption of cosmetics is expected to further boost demand for lactose monohydrate in the near future. However, availability of substitutes and shift towards natural ingredients in food may hamper market growth. New products developed with lactose monohydrate as an ingredient may bring prospective opportunities for future demand growth.

Geographically, Asia Pacific is estimated to be the key consumer as well as producer of lactose monohydrate. Key industrial economies including India, South Korea, Japan and China are the major markets for lactose monohydrate for utility in food, cosmetics and pharmaceuticals industry as an additive. High population growth and increasing purchase power parity, in China and India specifically, is likely to lead growth of demand for lactose monohydrate. Europe is another key market for lactose monohydrate in food industry and as an additive in infant formula. European Commission has approved use of lactose monohydrate in infant formula and for food supplements in older children. Demand growth for lactose monohydrate in North America is estimated to be driven by pharmaceuticals and food and beverages industry. Animal feed is also an attractive market segment in this region. In rest of the world Africa and Latin America have a high potential for growth due to the high growth of the pharmaceuticals industry and food and beverage industry.

Some of the market players include Sheffield Bio-Science Ltd., Lactose India Ltd., Hummel Croton Inc., Mallinckrodt Baker Inc. Meggle Group and Merck Millipore among others.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America

Asia Pacific

Europe

Rest of the World

Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Lactose monohydrate Market during 2015- 2023

www.transparencymarketresearch.com/sample/sample.php?flag…

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: www.transparencymarketresearch.com

This release was published on openPR.

Handhelds in Healthcare Market Research Report: Technological breakthroughs, Value chain and stakeholder analysis by 2023

Handhelds in Healthcare Market
Handhelds in Healthcare Market

The introduction of portable handheld devices has greatly influenced many fields, including medical science. Healthcare professionals now use various handheld devices to provide point-of-care services to patients across the world. The handhelds in healthcare market has witnessed a remarkable growth due to the development of portable and highly precise patient monitoring devices. Moreover, with the amalgamation of advance technologies such as cloud-based mobile healthcare services and telemedicine with the handheld devices it is expected that the handheld in healthcare market will experience a significant growth in the near future.

The major types of handheld devices used in the healthcare industry are as follows:

Patient information management devices

Personal digital assistants (PDAs)

Tablet computers

Smartphones

Patient monitoring devices

Pulse oximeters

Electrocardiogram (ECG/EKG)

Multiparameter monitors

Fetal heart monitors

Continuous glucose monitors

Blood pressure monitors

Portable ultrasound devies

Others

Some of the end-users of the handhelds in healthcare are as follows:

Hospitals

Pharmacies

Ambulatory care centers

Home healthcare

Nursing Homes

View Report-

www.transparencymarketresearch.com/handhelds-healthcare-m…

In terms of geographical analysis, North America followed by Europe account for the largest market share of handhelds in healthcare market due to the high adoption rate of mobile handheld devices in healthcare facilities and hospitals. Moreover, rising geriatric population in developed nations such as the U.S., U.K., Germany, France, Italy and Canada would further push the market growth of handheld devices in healthcare. According to the World Health Organization (WHO) estimates, the global geriatric population would reach around 2 billion (22% of the global population) by 2050, which was around 524 million in 2010. Moreover, according to the United Nations, the number of people aged 60 years and above is likely to increase from 841 million in 2013 to over 2 billion by 2050. Thus, the increasing base of geriatric population it is expected to drive the sales of handheld patient monitoring devices in the near future. Moreover, other regions such as Middle East, Latin America and South East Asia are expected to be the prospective markets in the near future. Due to the high adoption rate of handheld monitoring devices and highly developing healthcare industry, these regions are expected to be the potential market in the near future.

The global handhelds in healthcare market is witnessing an admirable growth due to the growing aging population, rising demand for medical process automation technologies and continuing product innovations. Furthermore, hospital supply cost limiting policies along with increased demand for error reduction in the healthcare industry are expected to boost the growth of overall handhelds in healthcare market in the near future. The major usage various handhelds devices lies within the established healthcare facilities that demands, rapid, accurate and biased free point-of-care tests results.

In addition, the use of portable handheld mobile devices in hospitals and pharmaceutical industry decreases human biases and enables easy data control and monitoring. Additionally, increasing usage of various mobile administrative devices such as PDA’s and tablet’s is further driving the growth of this market. These highly precise instruments are also extensively used in the patient data management process within the healthcare facility for maintaining the quality and uniformity. Thus, it has been expected that owing to the preciseness and accurate results of the handheld devices, these devices have the potential to revolutionize the work process of the overall healthcare industry. However, low commercial availability of product, low adoption rate and high pricing are few of the important factors that might act as hindrances for the growth of this market.

The global handhelds in healthcare market is robustly competitive and consolidated due to the contribution and presence of many established as well as emerging players in this market. The market is expected to witness a high growth rate due to the growing demand for mobile and portable handheld patient monitoring devices. Some of the key players involved in the handhelds in healthcare market are Apple, Inc, BlackBerry Limited, GE Healthcare, Honeywell International Inc., Hewlett-Packard Development Company, L.P., Medtronic plc, Motorola Solutions, Inc., Omron Corporation, Siemens Healthcare, Socket Mobile and Welch Allyn, Inc.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of

Market growth drivers

Factors limiting market growth

Current market trends

Market structure

Market projections for upcoming years

Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Handhelds in Healthcare Market during 2015- 2023

www.transparencymarketresearch.com/sample/sample.php?flag…

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: www.transparencymarketresearch.com

This release was published on openPR.